Under-utilisation of beta-blockers after acute myocardial infarction. Pharmacoeconomic implications.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 1999 AND VI 15 AND IP 3
Results: 10
1
2
Primary care purchasing. Are integrated primary care provider/purchasers the way forward?
- Published in:
- 1999
- By:
- Publication type:
- journal article
3
Pharmacoeconomic consequences of variable patient compliance with prescribed drug regimens.
- Published in:
- 1999
- By:
- Publication type:
- journal article
4
The economics of multiple sclerosis. Distribution of costs and relationship to disease severity.
- Published in:
- 1999
- By:
- Publication type:
- journal article
5
Patient self-reports in pharmacoeconomic studies. Their use and impact on study validity.
- Published in:
- 1999
- By:
- Publication type:
- journal article
6
Under-Utilisation of β-Blockers After Acute Myocardial Infarction: Pharmacoeconomic Implications.
- Published in:
- PharmacoEconomics, 1999, v. 15, n. 3, p. 257, doi. 10.2165/00019053-199915030-00005
- By:
- Publication type:
- Article
7
New drugs for osteoporosis. Comparison of the costs and required returns with those of other drugs intended for long-term use.
- Published in:
- 1999
- By:
- Publication type:
- journal article
8
Simvastatin after orthotopic heart transplantation. Costs and consequences.
- Published in:
- 1999
- By:
- Publication type:
- journal article
9
Pharmaceutical price regulation. A study on the impact of the rate-of-return regulation in the UK.
- Published in:
- 1999
- By:
- Publication type:
- journal article
10
Costs of peripheral blood progenitor cell transplantation using whole blood mobilised by filgrastim as compared with autologous bone marrow transplantation in non-Hodgkin's lymphoma.
- Published in:
- 1999
- By:
- Publication type:
- journal article